Evidence map›Paper›PMID 34341000›Full record

ReviewGenes & development2021

Solving the chromosome puzzle of aneuploidy in cancer.

Roberto Chiarle

Abstract readReview
In one paragraph

Review in Genes & development, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. MPS1 inhibition as an anticancer strategy: where do we stand?Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology · 2026
    Review
  2. Hepatoblastoma.Nature reviews. Disease primers · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. The Anaphase-Promoting Complex/Cyclosome Is a Cellular Ageing Regulator.International journal of molecular sciences · 2022
    Review
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Roberto ChiarleDepartment of Pathology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA; Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino 10126, Italy.ORCID 0000-0003-1564-8531

Funding

APOBEC proteins as drivers of chromosomal translocations in solid cancersR01CA222598 · NCI · BOSTON CHILDREN'S HOSPITAL · PI CHIARLE, ROBERTO · 2018 to 2022
$2.0M
NCI NIH HHS R01 CA222598
6 · The paper itself

Abstract

Chromosome instability (CIN) and aneuploidy are hallmarks of cancer cells, typically associated with aggressiveness and poor outcomes. Historically, the causative link between aneuploidy and cancer has been difficult to study due to its intrinsic complexity and the poor fitness of aneuploid cells. In this issue of

Indexed as

AneuploidyNeoplasmsAnimalsChromosomal InstabilityChromosome AberrationsKaryotypeMiceaneuploidycancerchromosome instabilityMyconcogenep53Plk4RAD21

Identifiers

PMID34341000
PMCPMC8336891

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.